Cardiovascular risk, epidemiology and prevention;Risque cardiovasculaire, épidémiologie, prévention

Medecine Therapeutique

Volumn 6, Issue 10, 2000, Pages 798-802

  Ducimetiere P ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CORONARY RISK; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; REVIEW;

EID: 0034490152     PISSN: 12646520     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. The world health organization MONICA project (monitoring trends and determinants in cardiovascular disease): A major international collaboration
2. A cooperative trial in the primary prevention of ischaemic heart disease using clofibrate
3. Multiple risk factor intervention trial: Risk factor changes and mortality results
4. Coronary heart disease in middle-aged Frenchmen. Comparisons between Paris prospective study, seven countries study and pooling project
5. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering
6. An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence
7. Short term reductions in blood pressure: Overview of randomized drug trials in their epidemiological context
8. Change in risk factors for coronary heart disease during 10 years of a community intervention program (North Karelia project)
9. Overview of results of randomized clinical trials in heart disease. I. Treatment following myocardial infarction
10. The beta-blocker pooling project (BBPP): Subgroup findings from randomized trials in post infarction patients
11. Secondary prevention of vascular disease by prolonged antiplatelet treatment
12. Meta-analysis of empirical long-term antiarrhythmic therapy after myocardial infarction
13. Randomized trial of cholesterol lowering in 4444 patients with coronary artery disease: The 4S study
14. Prevention of coronary disease with pravastatin in men with hypercholesterolemia
15. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes
16. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations
17. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA project populations
18. Estimation of contribution of changes in coronary care to improving survival, event rates and coronary heart disease mortality across the WHO MONICA project populations